• Profile
Close

Biocon cuts insulin price 50% in 'poor' countries

UNI Sep 28, 2019

Biocon Biologics reduced the retail price of its recombinant human insulin 50 per cent in the low-and-middle income countries, the biotech major said on 27th September.

"We will offer the anti-diabetic drug at 10 cents for 40 units of insulin required per patient per day in low-and-middle income countries," said the city-based bio-pharma firm in a statement. Biocon chairperson Kiran Mazumdar-Shaw announced the reduction in the cost of life-saving insulin at the joint United Nations Progamme on HIV and AIDS (UNAIDS) health innovation exchange meeting on 25th September on the margins of the UN General Assembly in New York. "Price should not be the reason to choose between life and death," said UNAIDS executive director Gunilla Carlsson on the occasion.

Over 400 million people worldwide are affected by diabetes. Evidence shows as they live longer, many people with HIV and on HIV treatment are becoming susceptible to non-communicable diseases. "AIDS activism has led to reducing the price of life-saving medicines and saving millions of lives. Our universal health coverage movement is benefiting from the lessons learned by the AIDS response," said Carlsson on the occasion. The Mumbai-based Wadhwani Institute for Artificial Intelligence, an independent, non-profit research institute and global hub, is developing artificial intelligence solutions for social good.

"The Institute has committed to set up a centre of excellence to leverage the use of artificial intelligence for global health," said the statement. The IoT has opened up huge possibilities in health: when connected to the Internet, ordinary medical devices can collect more data, give insight into symptoms and trends, enable remote care and give people more control over their lives and quality of treatment. Thought-Focus, a technology services firm, will provide access to its Internet of Things (IoT) platform to serve as an affordable, reliable and efficient way to build and extend IoT solutions for transportation, logistics, manufacturing and utilities related to health-care services.

"The IoT has opened up huge possibilities in health. When connected to the Internet, ordinary medical devices can collect more data, give insight into symptoms and trends, enable remote care and give people control over their lives and quality of treatment," said the statement. Zenysis, a technology firm, said it was investing $ 3.5 million to implement data pilots in five countries over the next three years for helping countries to make evidence-based decisions in rolling out universal health coverage and prioritizing investments in health systems. "The private sector has a key role to play in advancing the sustainable development goals," added Ms Carlsson.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay